“…Poultry industry, a rapidly growing food producing industry, requires efficacious and safe antibiotics that provide high efficacy and leaves minimal residues for treating diseases including chronic respiratory disease (caused by Mycoplasma gallisepticum ). The causative organism, M. gallisepticum, is highly sensitive to quinolones, tetracyclines, macrolides, and tiamulin (Arzey & Arzey, ; Yang et al ; Yang, Sun, Zhao, Wang, & Wang, ). Tiamulin, a pleuromutilin derivative, is an ideal anti‐mycoplasmal drug, due to its distinct advantages such as relatively high cure rate, very low “minimum inhibitory concentration” (MIC), least resistance development, and shorter withdrawal period (Islam, Klein, & Burch, ; Xia et al, ), and its use is approved in India.…”